Researchers from the pharmaceutical company Roche have published an article in ‘Nature,’ which discusses their discovery of a drug that works against resistant infections. It’s already being tested in humans
The novel combination therapy with atezolizumab and bevacizumab added to chemotherapy as first-line treatment in the ATRACTIB trial demonstrates significant.